6.21
+0.04(+0.65%)
Currency In USD
Address
4 Science Park
New Haven, CT 06511
United States of America
Phone
203 787 7888
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
51
First IPO Date
June 30, 2017
| Name | Title | Pay | Year Born |
| Mr. Ilan Danieli | Founder, President, Chief Executive Officer & Director | 325,065 | 1972 |
| Mr. Ahmed Zaki Sabet | Chief Operating Officer | 220,823 | 1986 |
| Dr. Ayman A. Mohamed M.D. | Chief Technology Officer | 225,145 | 1985 |
| Mr. Matthew Gage | Chief Financial Officer | 0 | 1967 |
| Ms. Miri Chiko-Radomski | Chief Legal Counsel & People Officer | 0 | N/A |
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.